Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Journal Title

Group by: Date | Item Type
Jump to: 2015 | 2013 | 2009 | 2005

2015

Human CD45RA(-) FoxP3(hi) memory-type regulatory T cells show distinct TCR repertoires with conventional T cells and play an important role in controlling early immune activation.
Lei, H., Kuchenbecker, L., Streitz, M., Sawitzki, B., Vogt, K., Landwehr-Kenzel, S., Millward, J., Juelke, K., Babel, N., Neumann, A., Reinke, P. and Volk, H.D.
American Journal of Transplantation 15 (10): 2625-2635. October 2015

2013

Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
Giral, M., Foucher, Y., Dufay, A., Van Huyen, J.P.D., Renaudin, K., Moreau, A., Philippe, A., Hegner, B., Dechend, R., Heidecke, H., Brouard, S., Cesbron, A., Castagnet, S., Devys, A., Soulillou, J.P. and Dragun, D.
American Journal of Transplantation 13 (10): 2567-2576. October 2013

2009

Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression.
Trappe, R., Hinrichs, C., Appel, U., Babel, N., Reinke, P., Neumayer, H.H., Budde, K., Dreyling, M., Duehrsen, U., Kliem, V., Schuettrumpf, S., Hauser, I.A., Mergenthaler, H.G., Schlattmann, P., Anagnostopoulos, I., Doerken, B. and Riess, H.
American Journal of Transplantation 9 (10): 2331-2337. October 2009

2005

Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).
Oertel, S.H., Verschuuren, E., Reinke, P., Zeidler, K., Papp-Vary, M., Babel, N., Trappe, R.U., Jonas, S., Hummel, M., Anagnostopoulos, I., Doerken, B. and Riess, H.B.
American Journal of Transplantation 5 : 2901-2906. 1 December 2005

This list was generated on Thu Aug 15 15:52:00 2024 UTC.
Open Access
MDC Library